Chang-Li Wang Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

6/2021	Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer.
1/2021	Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.
3/2020	Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.
1/2019	Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study.
10/2017	Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal.
6/2015	Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.
4/2015	Osteopontin-expressing macrophages in non-small cell lung cancer predict survival.
11/2014	A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).
12/2013	Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
12/2012	Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Li Wang Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 05/2009
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 12/2007
10	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2009
5	Neoplasm Metastasis (Metastasis) 10/2017 - 05/2009
3	Adenocarcinoma of Lung 03/2022 - 09/2016
2	Carcinogenesis 03/2022 - 10/2013
2	Lymphatic Metastasis 06/2015 - 10/2013
1	Circulating Neoplastic Cells 10/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Morphine Dependence 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 09/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2016
1	Stomach Neoplasms (Stomach Cancer) 10/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2013
1	Adenocarcinoma 04/2013
1	Malignant Mesothelioma 01/2012
1	Inflammation (Inflammations) 05/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2013
3	Messenger RNA (mRNA)IBA 03/2022 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
3	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2019
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 12/2012
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2009
3	Gefitinib (Iressa)FDA Link 11/2014 - 08/2009
2	Long Noncoding RNAIBA 03/2022 - 01/2020
2	ParaffinIBA 01/2022 - 10/2013
2	CytokinesIBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 10/2020 - 01/2019
2	OsteopontinIBA 04/2015 - 12/2013
1	Biological ProductsIBA 03/2022
1	Untranslated RNA (Noncoding RNA)IBA 03/2022
1	LigandsIBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Small Interfering RNA (siRNA)IBA 06/2021
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 06/2021
1	AntibodiesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	LipidsIBA 10/2020
1	CarcinogensIBA 03/2020
1	Oncogene Proteins (Oncogene Protein)IBA 03/2020
1	UbiquitinIBA 03/2020
1	n-dodecaneIBA 01/2020
1	lavender oilIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	CatecholaminesIBA 01/2020
1	EstersIBA 01/2020
1	PlatinumIBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2020
1	Ammonium CompoundsIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2019
1	AntigensIBA 01/2019
1	CalciumIBA 01/2019
1	Terfenadine (Seldane)IBA 10/2017
1	Taxoids (Taxanes)IBA 10/2017
1	Epirubicin (Ellence)FDA LinkGeneric 10/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2016
1	RNA (Ribonucleic Acid)IBA 09/2016
1	Claudin-1IBA 09/2016
1	puerarinIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2016
1	SolutionsIBA 04/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	AlkaloidsIBA 01/2016
1	icotinibIBA 11/2014
1	IntegrinsIBA 12/2013
1	StathminIBA 10/2013
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 04/2013
1	Activating Transcription Factor 2IBA 04/2013
1	Mitogen-Activated Protein KinasesIBA 04/2013
1	ClaudinsIBA 04/2013
1	Epidermal Growth Factor (EGF)IBA 12/2012
1	Cetuximab (Erbitux)FDA Link 12/2012
1	SuspensionsIBA 12/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2012
1	Radiation-Sensitizing AgentsIBA 08/2009
1	ChemokinesIBA 05/2009
1	CCR1 ReceptorsIBA 05/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2018
2	Neoadjuvant Therapy 01/2021 - 01/2019
2	Immunotherapy 01/2021 - 06/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2019
2	Pneumonectomy (Lung Volume Reduction) 12/2012 - 12/2007
2	Adjuvant Chemotherapy 12/2012 - 12/2007
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 10/2018
1	Precision Medicine 01/2017
1	Subcutaneous Injections 04/2016
1	Radiotherapy 06/2015